FERTILIZERS AND CHEMICALS TRAVANCORE: Q1 SL NET LOSS 619M RUPEES VS PROFIT 43M (YOY)

PARAMOUNT COMMUNICATIONS: Q1 EBITDA 347M RUPEES VS 151M (YOY) || Q1 EBITDA MARGIN 6.6% VS 3.4% (YOY)

PARAMOUNT COMMUNICATIONS: Q1 REVENUE 5.3B RUPEES VS 4.5B (YOY)

PARAMOUNT COMMUNICATIONS: Q1 SL NET PROFIT 200M RUPEES VS 190M (YOY)

TUBE INVESTMENTS: Q1 EBITDA 5.48B RUPEES VS 5.46B (YOY) || Q1 EBITDA MARGIN 8.8% VS 10.3% (YOY)

TUBE INVESTMENTS: Q1 REVENUE 62B RUPEES VS 53B (YOY)

TUBE INVESTMENTS: Q1 CONS NET PROFIT 1.7B RUPEES VS 3B (YOY)

NATCO PHARMA LIMITED: BOARD DECLARES INTERIM DIVIDEND OF ₹1.50 PER SHARE

NATCO PHARMA: CO APPROVED FUND RAISING UP TO 20B RUPEES

PRAKASH PIPES: Q1 EBITDA 182M RUPEES VS 163M (YOY) || Q1 EBITDA MARGIN 7.54% VS 8.01% (YOY)

PRAKASH PIPES: Q1 REVENUE 2.4B RUPEES VS 2B (YOY)

NATCO PHARMA: Q1 REVENUE 7.3B RUPEES VS 13.3B (YOY)

NATCO PHARMA: Q1 EBITDA 1.86B RUPEES VS 5.7B (YOY) || Q1 EBITDA MARGIN 25.4% VS 42.97% (YOY)

NATCO PHARMA: Q1 CONS NET PROFIT 2.1B RUPEES VS 4.8B (YOY)

PRAKASH PIPES: Q1 SL NET PROFIT 164M RUPEES VS 103M (YOY)

ALKEM LAB: Q1 REVENUE 37B RUPEES VS 33.7B (YOY)

ALKEM LAB: Q1 EBITDA 7.7B RUPEES VS 7.4B (YOY) || Q1 EBITDA MARGIN 20.48% VS 21.9% (YOY)